Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
University of Utah
Salt Lake City, Utah
The records below are financial disclosure and conflict of interest records obtained by ProPublica from the National Institutes of Health and dozens of large public universities across the country. The NIH only has records for researchers who seek or receive its funding.
Total Disclosures: 646. We're showing you the first 500 records. If you need every record from this institution, you can download all of our data at the ProPublica Data Store.
| Name | Type | Company | Disclosed Value | Year Filed |
|---|---|---|---|---|
| Gerald Krueger | Conflict of Interest | Novartis | $20,000-39,999 | 2012-2019 |
| Michael Deininger | Conflict of Interest | Novartis | $10,000-19,999 | 2012-2019 |
| Himanshu Sant | Conflict of Interest | Espira Inc | $10,000-19,999 | 2012-2019 |
| Scott Summers | Conflict of Interest | Centaurus Therapeutics | $10,000-19,999 | 2012-2019 |
| R. Lor | Conflict of Interest | Daiichi Sankyo | $10,000-19,999 | 2012-2019 |
| Michael Deininger | Conflict of Interest | Novartis | $10,000-19,999 | 2012-2019 |
| David Turok | Conflict of Interest | Teva Women's Health | $10,000-19,999 | 2012-2019 |
| Michael Kay | Conflict of Interest | Navigen | $10,000-19,999 | 2012-2019 |
| Jutta Deininger | Conflict of Interest | Pfizer | $10,000-19,999 | 2012-2019 |
| Michael Deininger | Conflict of Interest | Incyte | $10,000-19,999 | 2012-2019 |
| Tibor Kovacsovics | Conflict of Interest | Celgene | $10,000-19,999 | 2012-2019 |
| Gerald Krueger | Conflict of Interest | Abbott Pharmacutical | $10,000-19,999 | 2012-2019 |
| Gerald Krueger | Conflict of Interest | Eli Lilly | $10,000-19,999 | 2012-2019 |
| Gerald Krueger | Conflict of Interest | Amgen | $10,000-19,999 | 2012-2019 |
| Julia Batten | Conflict of Interest | Exelixis | $10,000-19,999 | 2012-2019 |
| Jeremiah Alt | Conflict of Interest | Glycomira Therapeutics | $10,000-19,999 | 2012-2019 |
| Gerald Krueger | Conflict of Interest | Facilitate of IDE | $10,000-19,999 | 2012-2019 |
| Michael Deininger | Conflict of Interest | Pfizer | $10,000-19,999 | 2012-2019 |
| Jutta Deininger | Conflict of Interest | Pfizer | $10,000-19,999 | 2012-2019 |
| Gerald Krueger | Conflict of Interest | Pfizer | $10,000-19,999 | 2012-2019 |
| Gerald Krueger | Conflict of Interest | Vascular Biologies Limited | $10,000-19,999 | 2012-2019 |
| R. Lor | Conflict of Interest | Daiichi Sankyo | $10,000-19,999 | 2012-2019 |
| Michael Deininger | Conflict of Interest | Novartis | $10,000-19,999 | 2012-2019 |
| Michael Deininger | Conflict of Interest | Novartis | $10,000-19,999 | 2012-2019 |
| Gerald Krueger | Conflict of Interest | Eli Lilly | $10,000-19,999 | 2012-2019 |
| Thomas Higgins | Conflict of Interest | Depuy Sythes | $10,000-19,999 | 2012-2019 |
| David Turok | Conflict of Interest | Teva Women's Health | $10,000-19,999 | 2012-2019 |
| Djordje Atanackovic | Conflict of Interest | Millennium Pharmaceuticals | $10,000-19,999 | 2012-2019 |
| Djordje Atanackovic | Conflict of Interest | Celgene | $10,000-19,999 | 2012-2019 |
| Michael Deininger | Conflict of Interest | Novartis | $10,000-19,999 | 2012-2019 |
| Gerald Krueger | Conflict of Interest | Eli Lilly | $10,000-19,999 | 2012-2019 |
| Tibor Kovacsovics | Conflict of Interest | Celgene | $10,000-19,999 | 2012-2019 |
| Sean Mulvihill | Conflict of Interest | N/A | $10,000-19,999 | 2012-2019 |
| Michael Kay | Conflict of Interest | Navigen | $10,000-19,999 | 2012-2019 |
| Tibor Kovacsovics | Conflict of Interest | Amgen | $10,000-19,999 | 2012-2019 |
| Djordje Atanackovic | Conflict of Interest | Millennium Pharmaceuticals | $10,000-19,999 | 2012-2019 |
| Thomas Higgins | Conflict of Interest | Depuy Sythes | $10,000-19,999 | 2012-2019 |
| Gerald Krueger | Conflict of Interest | Eli Lilly and Co. | $10,000-19,999 | 2012-2019 |
| Frederick Welt | Conflict of Interest | Medtronic | $10,000-19,999 | 2012-2019 |
| Ravi Ranjan | Conflict of Interest | St. Jude Medical | $10,000-19,999 | 2012-2019 |
| David Turok | Conflict of Interest | Teva Women's Health | $10,000-19,999 | 2012-2019 |
| Douglas Adler | Conflict of Interest | Boston Scientific | $10,000-19,999 | 2012-2019 |
| Michael Deininger | Conflict of Interest | Incyte | $10,000-19,999 | 2012-2019 |
| David Turok | Conflict of Interest | Teva Women's Health | $10,000-19,999 | 2012-2019 |
| Peter Stevens | Conflict of Interest | Orthofix, Inc | $10,000-19,999 | 2012-2019 |
| Michael Deininger | Conflict of Interest | Pfizer | $10,000-19,999 | 2012-2019 |
| Tibor Kovacsovics | Conflict of Interest | Amgen | $10,000-19,999 | 2012-2019 |
| Michael Deininger | Conflict of Interest | Incyte | $10,000-19,999 | 2012-2019 |
| Tibor Kovacsovics | Conflict of Interest | Amgen | $10,000-19,999 | 2012-2019 |
| Tibor Kovacsovics | Conflict of Interest | Celgene | $10,000-19,999 | 2012-2019 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.